|
|
post embryonic development
|
GO:0009791 |
2 |
0.989
|
|
|
|
mechanosensory behavior
|
GO:0007638 |
4 |
0.966
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.794
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.755
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
89 |
0.685
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.683
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.663
|
|
|
|
rna splicing
|
GO:0008380 |
131 |
0.656
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.653
|
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
22 |
0.613
|
|
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
1 |
0.611
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.592
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
89 |
0.539
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
90 |
0.532
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
61 |
0.510
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.503
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
48 |
0.495
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
41 |
0.490
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.478
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.468
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.436
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.431
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.418
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
62 |
0.416
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.405
|
|
|
|
heart formation
|
GO:0060914 |
2 |
0.385
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.369
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.356
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.348
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.345
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.340
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.336
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.294
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.284
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.280
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.268
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.264
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.249
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.246
|
|
|
|
positive regulation of small gtpase mediated signal transduction
|
GO:0051057 |
12 |
0.243
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.242
|
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
4 |
0.240
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.232
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.228
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.224
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.222
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.217
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.213
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
32 |
0.210
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.205
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.204
|
|
|
|
regulation of ubiquitin protein transferase activity
|
GO:0051438 |
28 |
0.203
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.202
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.200
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.198
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.192
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
94 |
0.189
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.186
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.172
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.170
|
|
|
|
gonad development
|
GO:0008406 |
34 |
0.169
|
|
|
|
growth
|
GO:0040007 |
202 |
0.168
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.165
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.162
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.159
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
1 |
0.158
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.155
|
|
|
|
wnt signaling pathway involved in heart development
|
GO:0003306 |
5 |
0.154
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.149
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
53 |
0.149
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.144
|
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
27 |
0.143
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.138
|
|
|
|
molting cycle
|
GO:0042303 |
28 |
0.137
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.135
|
|
|
|
response to axon injury
|
GO:0048678 |
1 |
0.133
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.131
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.130
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.122
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.122
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.120
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.118
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.116
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.115
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.114
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.113
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.113
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.112
|
|
|
|
canonical wnt signaling pathway involved in heart development
|
GO:0061316 |
3 |
0.112
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.111
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.109
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.105
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.105
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.104
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.102
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.102
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
33 |
0.102
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.102
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.101
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.101
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.099
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.097
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.096
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.094
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.094
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.093
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.092
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.092
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.091
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
4 |
0.090
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
76 |
0.089
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.087
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
18 |
0.087
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.087
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.087
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.087
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.086
|
|
|
|
positive regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030511 |
12 |
0.086
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.086
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.086
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.084
|
|
|
|
determination of dorsal ventral asymmetry
|
GO:0048262 |
4 |
0.084
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.084
|
|
|
|
heart field specification
|
GO:0003128 |
2 |
0.082
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.080
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
84 |
0.080
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.080
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
99 |
0.079
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.079
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.079
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.077
|
|
|
|
muscle organ morphogenesis
|
GO:0048644 |
19 |
0.077
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.077
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator
|
GO:0042771 |
23 |
0.077
|
|
|
|
sebaceous gland development
|
GO:0048733 |
1 |
0.075
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.075
|
|
|
|
mrna processing
|
GO:0006397 |
133 |
0.075
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.073
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.073
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.073
|
|
|
|
spindle organization
|
GO:0007051 |
53 |
0.072
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.072
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.072
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.072
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
48 |
0.072
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.072
|
|
|
|
positive regulation of proteasomal protein catabolic process
|
GO:1901800 |
35 |
0.071
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
37 |
0.071
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.070
|
|
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
85 |
0.070
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.069
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
35 |
0.067
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.067
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.066
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.066
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.066
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.066
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.064
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.064
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.063
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.063
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.062
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.062
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.061
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.061
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.061
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.061
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.060
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.060
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
60 |
0.060
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.060
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.059
|
|
|
|
cardiac muscle cell fate commitment
|
GO:0060923 |
4 |
0.059
|
|
|
|
gene silencing by rna
|
GO:0031047 |
26 |
0.059
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.058
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.058
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.057
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.057
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.055
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.055
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.054
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.054
|
|
|
|
positive regulation of response to alcohol
|
GO:1901421 |
3 |
0.054
|
|
|
|
regulation of ligase activity
|
GO:0051340 |
29 |
0.053
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.053
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.052
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.052
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.051
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.050
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.049
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
2 |
0.048
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.048
|
|
|
|
determination of bilateral symmetry
|
GO:0009855 |
15 |
0.047
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.047
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
25 |
0.047
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.047
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.046
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.046
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.046
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.046
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.046
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.046
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.045
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.045
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.044
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.044
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.044
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.043
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.043
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.043
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.043
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.043
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.043
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.043
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.043
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.042
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
28 |
0.042
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.042
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.041
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
37 |
0.041
|
|
|
|
heart induction
|
GO:0003129 |
4 |
0.041
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.041
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.040
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.040
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.040
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.040
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.040
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
26 |
0.039
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.039
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.038
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.038
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
73 |
0.038
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.037
|
|
|
|
positive regulation of stress activated protein kinase signaling cascade
|
GO:0070304 |
61 |
0.037
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.037
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
119 |
0.037
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.037
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.036
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.036
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.036
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
79 |
0.036
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.036
|
|
|
|
lung epithelium development
|
GO:0060428 |
7 |
0.036
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.035
|
|
|
|
regulation of establishment or maintenance of cell polarity
|
GO:0032878 |
7 |
0.035
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.035
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.034
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.034
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.034
|
|
|
|
protein stabilization
|
GO:0050821 |
64 |
0.033
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.033
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.033
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.033
|
|
|
|
genitalia development
|
GO:0048806 |
10 |
0.033
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.033
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.032
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.032
|
|
|
|
negative regulation of heart induction by canonical wnt signaling pathway
|
GO:0003136 |
1 |
0.032
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.032
|
|
|
|
striated muscle contraction
|
GO:0006941 |
52 |
0.031
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.031
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.031
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.031
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.031
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.031
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.031
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.031
|
|
|
|
sensory perception of sound
|
GO:0007605 |
37 |
0.031
|
|
|
|
memory
|
GO:0007613 |
3 |
0.031
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
3 |
0.030
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.030
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.030
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.030
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.030
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.030
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.030
|
|
|
|
protein k48 linked ubiquitination
|
GO:0070936 |
38 |
0.029
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.029
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
38 |
0.029
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.029
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.029
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.029
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
3 |
0.029
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.029
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.029
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.028
|
|
|
|
regulation of protein polymerization
|
GO:0032271 |
63 |
0.028
|
|
|
|
b cell activation
|
GO:0042113 |
33 |
0.028
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.028
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.028
|
|
|
|
regulation of catenin import into nucleus
|
GO:0035412 |
18 |
0.028
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.027
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.027
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.027
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.027
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.027
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.027
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.027
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.027
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.027
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.027
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.026
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
4 |
0.026
|
|
|
|
negative regulation of cardioblast differentiation
|
GO:0051892 |
2 |
0.026
|
|
|
|
negative regulation of protein modification by small protein conjugation or removal
|
GO:1903321 |
41 |
0.026
|
|
|
|
regulation of heart induction
|
GO:0090381 |
2 |
0.026
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.026
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.026
|
|
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
35 |
0.026
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.026
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.026
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.026
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.025
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.025
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.025
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.025
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
38 |
0.025
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
37 |
0.025
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.025
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.025
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.025
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.025
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.025
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.025
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
2 |
0.025
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.025
|
|
|
|
cardiac cell fate commitment
|
GO:0060911 |
7 |
0.024
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.024
|
|
|
|
protein sumoylation
|
GO:0016925 |
25 |
0.024
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.024
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
73 |
0.024
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.024
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.024
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.024
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.024
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.024
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.024
|
|
|
|
establishment or maintenance of epithelial cell apical basal polarity
|
GO:0045197 |
1 |
0.024
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.024
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.024
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.023
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.023
|
|
|
|
organ induction
|
GO:0001759 |
4 |
0.023
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.023
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.023
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.023
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.023
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.023
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.022
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.022
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.022
|
|
|
|
determination of left right asymmetry in lateral mesoderm
|
GO:0003140 |
1 |
0.022
|
|
|
|
vitamin d receptor signaling pathway
|
GO:0070561 |
4 |
0.022
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.022
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.022
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.022
|
|
|
|
mrna stabilization
|
GO:0048255 |
18 |
0.022
|
|
|
|
lamellipodium organization
|
GO:0097581 |
30 |
0.022
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.022
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.022
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
35 |
0.022
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.022
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.022
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.022
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.021
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.021
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003256 |
3 |
0.021
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.021
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
23 |
0.021
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.021
|
|
|
|
jnk cascade
|
GO:0007254 |
80 |
0.021
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
38 |
0.021
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
29 |
0.021
|
|
|
|
positive regulation of vitamin d receptor signaling pathway
|
GO:0070564 |
2 |
0.021
|
|
|
|
response to insulin
|
GO:0032868 |
45 |
0.021
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.020
|
|
|
|
secondary heart field specification
|
GO:0003139 |
2 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.020
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.020
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
1 |
0.020
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.020
|
|
|
|
positive regulation of mitochondrial depolarization
|
GO:0051901 |
3 |
0.020
|
|
|
|
ear morphogenesis
|
GO:0042471 |
7 |
0.020
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.020
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.020
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.020
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.020
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.020
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
41 |
0.020
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.020
|
|
|
|
convergent extension
|
GO:0060026 |
1 |
0.020
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.020
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.019
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
42 |
0.019
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.019
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.019
|
|
|
|
mitotic spindle organization
|
GO:0007052 |
27 |
0.019
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.019
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.019
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.019
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.019
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.019
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.019
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
24 |
0.019
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.019
|
|
|
|
system process
|
GO:0003008 |
349 |
0.019
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.019
|
|
|
|
spindle elongation
|
GO:0051231 |
4 |
0.019
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.018
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.018
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.018
|
|
|
|
positive regulation of ubiquitin protein transferase activity
|
GO:0051443 |
18 |
0.018
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.018
|
|
|
|
hard palate development
|
GO:0060022 |
1 |
0.018
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.018
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.018
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
27 |
0.018
|
|
|
|
regulation of organ formation
|
GO:0003156 |
4 |
0.018
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
80 |
0.018
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.018
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.018
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.018
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.018
|
|
|
|
positive regulation of dendrite morphogenesis
|
GO:0050775 |
3 |
0.017
|
|
|
|
establishment of epithelial cell polarity
|
GO:0090162 |
2 |
0.017
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.017
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.017
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
37 |
0.017
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
53 |
0.017
|
|
|
|
male meiosis
|
GO:0007140 |
1 |
0.017
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.017
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
35 |
0.017
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.017
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
12 |
0.017
|
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
51 |
0.017
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.017
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.017
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.016
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
9 |
0.016
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.016
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
1 |
0.016
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.016
|
|
|
|
axis elongation
|
GO:0003401 |
4 |
0.016
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
3 |
0.016
|
|
|
|
specification of symmetry
|
GO:0009799 |
16 |
0.016
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.016
|
|
|
|
positive regulation of multicellular organism growth
|
GO:0040018 |
6 |
0.016
|
|
|
|
regulation of axon regeneration
|
GO:0048679 |
1 |
0.016
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.016
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.016
|
|
|
|
rna catabolic process
|
GO:0006401 |
71 |
0.016
|
|
|
|
cardioblast cell fate specification
|
GO:0042685 |
1 |
0.016
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.016
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
83 |
0.016
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.016
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.015
|
|
|
|
detection of stimulus
|
GO:0051606 |
85 |
0.015
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
54 |
0.015
|
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
1 |
0.015
|
|
|
|
nucleus organization
|
GO:0006997 |
28 |
0.015
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.015
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.015
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.015
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.015
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.015
|
|
|
|
type b pancreatic cell development
|
GO:0003323 |
4 |
0.015
|
|
|
|
positive regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032436 |
30 |
0.015
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
2 |
0.015
|
|
|
|
establishment or maintenance of monopolar cell polarity
|
GO:0061339 |
1 |
0.015
|
|
|
|
organelle localization
|
GO:0051640 |
84 |
0.015
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.015
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.015
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.015
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
47 |
0.015
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.015
|
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
1 |
0.015
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.014
|
|
|
|
viral gene expression
|
GO:0019080 |
35 |
0.014
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.014
|
|
|
|
retina layer formation
|
GO:0010842 |
3 |
0.014
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.014
|
|
|
|
regulation of multicellular organism growth
|
GO:0040014 |
8 |
0.014
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.014
|
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.014
|
|
